Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial
Cherry-Ann Waldron(Cardiff University), Sanjay V. Patel(University Hospital Southampton NHS Foundation Trust), Jolanta Bernatoniene(Bristol Royal Hospital for Children), Kim Smallman, Sue Channon(Cardiff University), Judith F. Evans, Josie Henley, Simon Schoenbuchner(Cardiff University), Emma Thomas‐Jones(Cardiff University), Chao Huang(University of Hull), Colin Powell(St. Vincent's University Hospital), Stéphane Paulus(University of Liverpool), Céu Mateus(University Dermatology), Lucy Hinds(Sheffield Children's NHS Foundation Trust), Debbie Harris(Cardiff University), Sarah Jones(Health and Care Research Wales), Philip Pallmann(University of Liverpool), Helen Nabwera(Liverpool School of Tropical Medicine), Katrina Cathie(University Hospital Southampton NHS Foundation Trust), Saul N. Faust(University Hospital Southampton NHS Foundation Trust), Sarah Milosevic(Leeds Teaching Hospitals NHS Trust), Enitan D. Carrol(University of Liverpool), Lucy Brookes‐Howell(Cardiff University), Huasheng Xiang(Beijing Jiaotong University), Hayley Prout(Cardiff University), Sarah E. Jones(Breast Center), Mark Goddard, Sarah J. Kotecha(Cardiff University), Kerenza Hood(NHS Digital), Waku Maboshe
Cited by 14
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k
Adaptive designs in clinical trials: why use them, and how to run and report them
|BMC Medicine|2018|826